Indivior Pharmaceuticals (INDV) Shares Outstanding (Diluted Average) (2022 - 2026)

Indivior Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $129.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 3.2% year-over-year to $129.0 million; the TTM figure through Mar 2026 stood at $129.0 million (up 3.2% YoY), while the FY2025 annual figure was $128.0 million, down 3.76% from the prior year.
• Shares Outstanding (Diluted Average) was $129.0 million for Q1 2026 at Indivior Pharmaceuticals, up from $128.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $139.0 million in Q4 2022 to a low of $125.0 million in Q1 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $131.9 million across 5 years, with a median of $133.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) decreased 8.76% in 2025, then grew 3.2% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $139.0 million in 2022, then slipped by 1.44% to $137.0 million in 2023, then retreated by 2.92% to $133.0 million in 2024, then declined by 3.76% to $128.0 million in 2025, then grew by 0.78% to $129.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $129.0 million (Q1 2026), $128.0 million (Q4 2025), and $129.0 million (Q3 2025), per Business Quant data.